Results 171 to 180 of about 856,848 (312)

How many trees are there in the North American boreal forest?

open access: yesEcography, EarlyView.
Boreal forests, the largest terrestrial biome on Earth, are highly varied in local tree density. Despite previous attempts to estimate tree density in boreal forests, the accuracy of the estimation is unknown, leaving the question how many trees there are in boreal forests largely unanswered. Here, we compiled tree density data from 4367 plots in North
Kun Xu   +4 more
wiley   +1 more source

Editorial: Current perspectives on the use of entomopathogenic fungi for pest control. [PDF]

open access: yesFront Fungal Biol
Angelo IC   +3 more
europepmc   +1 more source

When natural habitat fails to enhance biological pest control – Five hypotheses ☆

open access: yes, 2016
T. Tscharntke   +20 more
semanticscholar   +1 more source

Evolutionary trajectories of multiple defense traits across phylogenetic and geographic scales in Vitis

open access: yesEcography, EarlyView.
The processes driving defense trait correlations may vary within and between species based on ecological or environmental contexts. However, most studies of plant defense theory fail to address this potential for shifts in trait correlations across scales.
Carolyn D. K. Graham, Marjorie G. Weber
wiley   +1 more source

CardiLect: A combined cross‐species lectin histochemistry protocol for the automated analysis of cardiac remodelling

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1398-1415, April 2025.
Abstract Background Cardiac remodelling, a crucial aspect of heart failure, is commonly investigated in preclinical models by quantifying cardiomyocyte cross‐sectional area (CSA) and microvascular density (MVD) via histological methods, such as immunohistochemistry.
Tamás G. Gergely   +14 more
wiley   +1 more source

Current and novel biomarkers in cardiogenic shock

open access: yesEuropean Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy